R.W. Retallack

899 total citations
39 papers, 657 citations indexed

About

R.W. Retallack is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, R.W. Retallack has authored 39 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in R.W. Retallack's work include Bone health and treatments (11 papers), Medical Imaging and Pathology Studies (7 papers) and Vitamin D Research Studies (6 papers). R.W. Retallack is often cited by papers focused on Bone health and treatments (11 papers), Medical Imaging and Pathology Studies (7 papers) and Vitamin D Research Studies (6 papers). R.W. Retallack collaborates with scholars based in Australia. R.W. Retallack's co-authors include Donald H. Gutteridge, G.N. Kent, Bronwyn Stuckey, C.I. Bhagat, Richard L. Prince, Roger I. Price, G.O. Stewart, Mary F. Lockett, PR Jefferies and R. Will and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, The Journal of Physiology and Biochemical and Biophysical Research Communications.

In The Last Decade

R.W. Retallack

38 papers receiving 610 citations

Peers

R.W. Retallack
J. Birmingham Australia
R.J. Bryant United States
V Pacovský Czechia
Michael Beach United States
Uģis Gruntmanis United States
Robert C. Kopelman United States
Anne Vienne Belgium
Silvia Lopez-Hilker United States
J. Birmingham Australia
R.W. Retallack
Citations per year, relative to R.W. Retallack R.W. Retallack (= 1×) peers J. Birmingham

Countries citing papers authored by R.W. Retallack

Since Specialization
Citations

This map shows the geographic impact of R.W. Retallack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.W. Retallack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.W. Retallack more than expected).

Fields of papers citing papers by R.W. Retallack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.W. Retallack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.W. Retallack. The network helps show where R.W. Retallack may publish in the future.

Co-authorship network of co-authors of R.W. Retallack

This figure shows the co-authorship network connecting the top 25 collaborators of R.W. Retallack. A scholar is included among the top collaborators of R.W. Retallack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.W. Retallack. R.W. Retallack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walsh, John P., Lynley Ward, G.O. Stewart, et al.. (2004). A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone. Bone. 34(4). 747–754. 65 indexed citations
5.
Retallack, R.W., Donald H. Gutteridge, Roger I. Price, et al.. (2000). Calcium Absorption in Postmenopausal Osteoporosis: Benefit of HRT Plus Calcitriol, but not HRT Alone, in both Malabsorbers and Normal Absorbers. Osteoporosis International. 11(1). 43–51. 17 indexed citations
6.
Stewart, G.O., Donald H. Gutteridge, Roger I. Price, et al.. (1999). Prevention of appendicular bone loss in Paget’s disease following treatment with intravenous pamidronate disodium. Bone. 24(2). 139–144. 20 indexed citations
7.
Gutteridge, Donald H., R.W. Retallack, Lynley Ward, et al.. (1996). Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: A 2-year study. Bone. 19(4). 387–394. 38 indexed citations
8.
Kent, G.N., P Garcia‐Webb, C.I. Bhagat, et al.. (1996). Comparison of biochemical markers of bone turnover in paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links. Journal of Bone and Mineral Research. 11(8). 1176–1184. 61 indexed citations
9.
Stuckey, Bronwyn, Donald H. Gutteridge, G.O. Stewart, et al.. (1994). Intravenous pamidronate in Paget's disease—Response is dependent on radiographic and biochemical severity. Seminars in Arthritis and Rheumatism. 23(4). 286–286. 2 indexed citations
10.
Kent, G.N., Roger I. Price, Donald H. Gutteridge, et al.. (1993). Effect of pregnancy and lactation on maternal bone mass and calcium metabolism. Osteoporosis International. 3(S1). 44–47. 73 indexed citations
11.
Gutteridge, Donald H., G.N. Kent, R. L. Prince, et al.. (1993). Fluoride treatment of osteoporosis: Cyclical non-blinded or continuous blinded studies?. Osteoporosis International. 3(S1). 215–217. 3 indexed citations
12.
Prince, Richard L., Ian M. Dick, P Garcia‐Webb, & R.W. Retallack. (1990). The Effects of the Menopause on Calcitriol and Parathyroid Hormone: Responses to a Low Dietary Calcium Stress Test*. The Journal of Clinical Endocrinology & Metabolism. 70(4). 1119–1123. 32 indexed citations
13.
Nicholson, Geoffrey C., Jacqueline C. Kent, Donald H. Gutteridge, & R.W. Retallack. (1985). ESTIMATION OF 1,25 DIHYDROXYVITAMIN D BY CYTORECEPTOR AND COMPETITIVE PROTEIN BINDING ASSAYS WITHOUT HIGH PRESSURE LIQUID CHROMATOGRAPHY. Clinical Endocrinology. 22(5). 597–609. 15 indexed citations
14.
Retallack, R.W., et al.. (1981). Abnormal thyroid stimulating hormone following pituitary surgery. Journal of Endocrinological Investigation. 4(2). 233–236. 1 indexed citations
15.
Retallack, R.W., et al.. (1976). Physiological hyperparathyroidism in human lactation. Calcified Tissue International. 22(S1). 142–146. 24 indexed citations
16.
CANNON, J. R., et al.. (1975). Structures of nine quinones isolated from two species. Tetrahedron Letters. 16(32). 2795–2798. 25 indexed citations
17.
Retallack, R.W., et al.. (1971). Pharmacological activity in aqueous extracts of scaevola spinescens. Pharmacological Research Communications. 3(3). 261–270.
18.
Lockett, Mary F. & R.W. Retallack. (1971). The release of a renally active substance by perfused rat hearts. The Journal of Physiology. 212(3). 733–738. 7 indexed citations
19.
Jefferies, PR & R.W. Retallack. (1968). The chemistry of the Euphorbiaceae. XX. Further compounds from Beyeria leschenaultii 12β,17-Dihydroxy-16α-(–)-kauran-19-oic acid. Australian Journal of Chemistry. 21(8). 2085–2093. 15 indexed citations
20.
Baddeley, G., P.R. Jefferies, & R.W. Retallack. (1964). Chemistry of the euphorbiaceae—IX. Tetrahedron. 20(8). 1983–1985. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026